IFM Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
21,297
+49
| +0.2% | +$25.7K | 0.11% | 181 |
|
|
2025
Q1 | $13.5M | Sell |
21,248
-102
| -0.5% | -$64.7K | 0.15% | 134 |
|
|
2024
Q4 | $15.2M | Sell |
21,350
-1,935
| -8% | -$1.38M | 0.15% | 118 |
|
|
2024
Q3 | $24.5M | Buy |
23,285
+27
| +0.1% | +$28.4K | 0.23% | 79 |
|
|
2024
Q2 | $24.4M | Buy |
23,258
+690
| +3% | +$725K | 0.25% | 78 |
|
|
2024
Q1 | $21.7M | Sell |
22,568
-134
| -0.6% | -$129K | 0.24% | 82 |
|
|
2023
Q4 | $19.9M | Sell |
22,702
-58
| -0.3% | -$50.9K | 0.24% | 84 |
|
|
2023
Q3 | $18.7M | Buy |
22,760
+1,859
| +9% | +$1.53M | 0.25% | 80 |
|
|
2023
Q2 | $15M | Buy |
20,901
+1,045
| +5% | +$751K | 0.2% | 97 |
|
|
2023
Q1 | $16.3M | Buy |
19,856
+466
| +2% | +$383K | 0.25% | 84 |
|
|
2022
Q4 | $14M | Buy |
19,390
+501
| +3% | +$361K | 0.23% | 94 |
|
|
2022
Q3 | $13M | Buy |
18,889
+376
| +2% | +$259K | 0.24% | 84 |
|
|
2022
Q2 | $10.9M | Buy |
18,513
+1,104
| +6% | +$653K | 0.19% | 107 |
|
|
2022
Q1 | $12.2M | Buy |
17,409
+3,659
| +27% | +$2.56M | 0.19% | 102 |
|
|
2021
Q4 | $8.68M | Sell |
13,750
-66
| -0.5% | -$41.7K | 0.16% | 123 |
|
|
2021
Q3 | $8.36M | Sell |
13,816
-35
| -0.3% | -$21.2K | 0.17% | 114 |
|
|
2021
Q2 | $7.74M | Buy |
13,851
+2,308
| +20% | +$1.29M | 0.16% | 132 |
|
|
2021
Q1 | $5.46M | Buy |
11,543
+1,523
| +15% | +$721K | 0.15% | 139 |
|
|
2020
Q4 | $4.84M | Buy |
10,020
+1,739
| +21% | +$840K | 0.15% | 132 |
|
|
2020
Q3 | $4.64M | Buy |
8,281
+1,132
| +16% | +$634K | 0.19% | 106 |
|
|
2020
Q2 | $4.46M | Sell |
7,149
-1,106
| -13% | -$690K | 0.23% | 90 |
|
|
2020
Q1 | $3.91M | Buy |
8,255
+249
| +3% | +$118K | 0.17% | 130 |
|
|
2019
Q4 | $3.01M | Sell |
8,006
-343
| -4% | -$129K | 0.11% | 197 |
|
|
2019
Q3 | $2.32M | Buy |
8,349
+2,415
| +41% | +$670K | 0.09% | 249 |
|
|
2019
Q2 | $1.86M | Buy |
5,934
+588
| +11% | +$184K | 0.11% | 209 |
|
|
2019
Q1 | $2.2M | Buy |
5,346
+765
| +17% | +$314K | 0.14% | 161 |
|
|
2018
Q4 | $1.71M | Buy |
4,581
+426
| +10% | +$159K | 0.14% | 160 |
|
|
2018
Q3 | $1.68M | Buy |
4,155
+588
| +16% | +$238K | 0.13% | 172 |
|
|
2018
Q2 | $1.23M | Buy |
3,567
+1,115
| +45% | +$385K | 0.12% | 186 |
|
|
2018
Q1 | $844K | Buy |
2,452
+262
| +12% | +$90.2K | 0.12% | 185 |
|
|
2017
Q4 | $823K | Hold |
2,190
| – | – | 0.13% | 175 |
|
|
2017
Q3 | $979K | Buy |
2,190
+45
| +2% | +$20.1K | 0.17% | 142 |
|
|
2017
Q2 | $1.05M | Buy |
2,145
+517
| +32% | +$254K | 0.19% | 124 |
|
|
2017
Q1 | $631K | Buy |
1,628
+611
| +60% | +$237K | 0.16% | 150 |
|
|
2016
Q4 | $373K | Buy |
+1,017
| New | +$373K | 0.18% | 151 |
|